Post-FMT analyses revealed the increased activation of CD8+ T-cells, a key component of antitumor immunity, alongside a reduction in interleukin-8 expression from myeloid cells, which is often associated with an immunosuppressive tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.